Lorenzo Bertani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Journal of clinical medicine

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Luisa Bertin, Brigida Barberio, Alessandro Gubbiotti, Lorenzo Bertani, Francesco Costa, Linda Ceccarelli, Pierfrancesco Visaggi, Giorgia Bodini, Andrea Pasta, Renato Sablich, Maria Teresa Urbano, Antonio Ferronato, Andrea Buda, Manuela De Bona, Giulio Del Corso, Alessandro Massano, Imerio Angriman, Marco Scarpa, Fabiana Zingone, Edoardo Vincenzo Savarino
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease. Journal of clinical medicine 13 (6) (2024)
Lorenzo Bertani, Luca Antonioli, Marco Fornili, Vanessa D'Antongiovanni, Linda Ceccarelli, Luca Carmisciano, Laura Benvenuti, Maria Gloria Mumolo, Andrea Bottari, Veronica Pardi, Giovanni Baiano Svizzero, Laura Baglietto, Nicola De Bortoli, Massimo Bellini, Matteo Fornai, Francesco Costa
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study. Inflammatory bowel diseases (2024)
Luisa Bertin, Brigida Barberio, Alessandro Gubbiotti, Lorenzo Bertani, Francesco Costa, Linda Ceccarelli, Pierfrancesco Visaggi, Giorgia Bodini, Andrea Pasta, Renato Sablich, Maria Teresa Urbano, Antonio Ferronato, Andrea Buda, Manuela De Bona, Giulio Del Corso, Alessandro Massano, Imerio Angriman, Marco Scarpa, Fabiana Zingone, Edoardo Vincenzo Savarino
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease. Journal of clinical medicine 13 (6) (2024)
Lorenzo Bertani, Claudia D'Alessandro, Marco Fornili, Francesca Coppini, Federico Zanzi, Luca Carmisciano, Francesca Geri, Giovanni Baiano Svizzero, Emma Maria Rosi, Alice De Bernardi, Linda Ceccarelli, Maria Gloria Mumolo, Laura Baglietto, Massimo Bellini, Nicola de Bortoli, Francesco Costa
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease. Journal of clinical medicine 12 (19) (2023)
Giorgio Guglielmi, Stefania Crucitta, Lorenzo Bertani, Martina Ruglioni, Giovanni Baiano Svizzero, Linda Ceccarelli, Marzia Del Re, Romano Danesi, Francesco Costa, Stefano Fogli
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics. Inflammatory bowel diseases (2023)
Alessandro Massano, Luisa Bertin, Fabiana Zingone, Andrea Buda, Pierfrancesco Visaggi, Lorenzo Bertani, Nicola de Bortoli, Angelo Paolo Dei Tos, Melania Scarpa, Cesare Ruffolo, Imerio Angriman, Cristina Bezzio, Valentina Casini, Davide Giuseppe Ribaldone, Edoardo Vincenzo Savarino, Brigida Barberio
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review. Cancers 15 (15) (2023)
Lorenzo Bertani, Domenico Tricò
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue. Alimentary pharmacology & therapeutics 56 (5) (2022)
Brigida Barberio, Edoardo Savarino, Bram Verstockt, Mathurin Fumery, Daniela Pugliese, Lorenzo Bertani, Andrea Buda, Gabriele Dragoni, Idan Goren, Ido Laish, Antonino Spinelli, Niels Teich, Marie Truyens, Pierre Ellul
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series. Journal of Crohn's & colitis 16 (12) (2022)
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Gionata Fiorino, Lucrezia Laterza, Anna Viola, Lorenzo Bertani, Flavio Caprioli, Maria Cappello, Brigida Barberio, Chiara Ricci, Paola Balestrieri, Marco Daperno, Dario Pluchino, Fernando Rizzello, Maria Lia Scribano, Renato Sablich, Luca Pastorelli, Francesco Manguso, Angela Variola, Antonio Di Sario, Laurino Grossi, Alessandro Armuzzi, null null
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study. Alimentary pharmacology & therapeutics 56 (1) (2022)
Lorenzo Bertani
Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices. Journal of clinical medicine 11 (18) (2022)
Davide Massimi, Brigida Barberio, Lorenzo Bertani, Francesco Costa, Antonio Ferronato, Sonia Facchin, Romilda Cardin, Linda Cingolani, Cesare Casadei, Renata D'Incà, Fabiana Zingone, Edoardo Vincenzo Savarino
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study. Therapeutic advances in gastroenterology 14 (2021)
Luca Antonioli, Carolina Pellegrini, Matteo Fornai, Laura Benvenuti, Vanessa D'Antongiovanni, Rocchina Colucci, Lorenzo Bertani, Clelia Di Salvo, Giorgia Semeghini, Concettina La Motta, Laura Giusti, Lorenzo Zallocco, Maurizio Ronci, Luca Quattrini, Francesco Angelucci, Vito Coviello, Won Keun Oh, Quy Thi Kim Ha, Zoltan H Németh, Gyorgy Haskó, Corrado Blandizzi
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. International journal of molecular sciences 22 (12) (2021)
Lorenzo Bertani, Brigida Barberio, Domenico Tricò, Federico Zanzi, Daria Maniero, Linda Ceccarelli, Ilaria Marsilio, Francesca Coppini, Greta Lorenzon, Maria Gloria Mumolo, Fabiana Zingone, Francesco Costa, Edoardo Vincenzo Savarino
Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. Journal of clinical medicine 10 (15) (2021)
Lorenzo Bertani, Daniela Pugliese, Domenico Tricò, Francesco Costa, Corrado Blandizzi
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply. Alimentary pharmacology & therapeutics 53 (2) (2021)
Lorenzo Bertani, Davide Giuseppe Ribaldone, Massimo Bellini, Maria Gloria Mumolo, Francesco Costa
Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions? Nutrients 13 (4) (2021)
Jessica Cusato, Lorenzo Bertani, Miriam Antonucci, Cristina Tomasello, Gian Paolo Caviglia, Simone Dibitetto, Alessandro Massano, Michela Mangia, Jacopo Mula, Linda Ceccarelli, Francesco Costa, Federico Zanzi, Marco Astegiano, Davide Giuseppe Ribaldone, Antonio D'Avolio
Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Brigida Barberio, Linda Cingolani, Cristina Canova, Giulia Barbieri, Renato Sablich, Maria Teresa Urbano, Lorenzo Bertani, Francesco Costa, Giorgia Bodini, Maria Giulia Demarzo, Antonio Ferronato, Andrea Buda, Piera Melatti, Davide Massimi, Edoardo Vincenzo Savarino, Fabiana Zingone
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study. Therapeutic advances in gastroenterology 14 (2021)
Lorenzo Bertani, Domenico Tricò, Federico Zanzi, Giovanni Baiano Svizzero, Francesca Coppini, Nicola de Bortoli, Massimo Bellini, Luca Antonioli, Corrado Blandizzi, Santino Marchi
Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis. Nutrients 13 (2) (2021)
Massimo Bellini, Sara Tonarelli, Maria Gloria Mumolo, Francesco Bronzini, Andrea Pancetti, Lorenzo Bertani, Francesco Costa, Angelo Ricchiuti, Nicola de Bortoli, Santino Marchi, Alessandra Rossi
Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome? Nutrients 12 (11) (2020)
Lorenzo Bertani, Matteo Fornai, Marco Fornili, Luca Antonioli, Laura Benvenuti, Gherardo Tapete, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Francesco Costa, Corrado Blandizzi
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab. Alimentary pharmacology & therapeutics 52 (2) (2020)
Lorenzo Bertani, Laura Baglietto, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Eleonora Albano, Linda Ceccarelli, Maria Gloria Mumolo, Carolina Pellegrini, Ersilia Lucenteforte, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Corrado Blandizzi, Francesco Costa
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients. British journal of clinical pharmacology 86 (7) (2020)
Massimo Bellini, Sara Tonarelli, Federico Barracca, Riccardo Morganti, Andrea Pancetti, Lorenzo Bertani, Nicola de Bortoli, Francesco Costa, Marta Mosca, Santino Marchi, Alessandra Rossi
A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up. Nutrients 12 (8) (2020)
Simone Saibeni, Ludovica Scucchi, Gabriele Dragoni, Cristina Bezzio, Agnese Miranda, Davide Giuseppe Ribaldone, Angela Bertani, Fabrizio Bossa, Mariangela Allocca, Andrea Buda, Gianmarco Mocci, Alessandra Soriano, Silvia Mazzuoli, Lorenzo Bertani, Flavia Baccini, Erika Loddo, Antonino Carlo Privitera, Alessandro Sartini, Angelo Viscido, Laurino Grossi, Valentina Casini, Viviana Gerardi, Marta Ascolani, Mirko Di Ruscio, Giovanni Casella, Edoardo Savarino, Davide Stradella, Rossella Pumpo, Claudio Camillo Cortelezzi, Marco Daperno, Valeria Ciardo, Olga Maria Nardone, Flavio Caprioli, Giovanna Vitale, Maria Cappello, Michele Comberlato, Patrizia Alvisi, Stefano Festa, Michele Campigotto, Giorgia Bodini, Paola Balestrieri, Anna Viola, Daniela Pugliese, Alessandro Armuzzi, Massimo C Fantini, Gionata Fiorino, null null
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European gastroenterology journal 8 (10) (2020)
Lorenzo Bertani, Domenico Tricò, Daniela Pugliese, Giuseppe Privitera, Giuseppe Linsalata, Federico Zanzi, Maria Gloria Mumolo, Brigida Barberio, Fabio Monzani, Santino Marchi, Luisa Guidi, Corrado Blandizzi, Alessandro Armuzzi, Francesco Costa
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients. Alimentary pharmacology & therapeutics 53 (2) (2020)
Lorenzo Bertani, Luca Antonioli, Corrado Blandizzi
Letter: ustekinumab's effectiveness outcomes compared with vedolizumab in Crohn's disease-what about mucosal healing and biomarkers? Alimentary pharmacology & therapeutics 52 (4) (2020)
Lorenzo Bertani, Matteo Fornai, Luca Antonioli, Corrado Blandizzi
Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab-authors' reply. Alimentary pharmacology & therapeutics 52 (6) (2020)
Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Barbara Tolusso, Clara Di Mario, Eleonora Albano, Gherardo Tapete, Elisa Gremese, Alfredo Papa, Antonio Gasbarrini, Gian Ludovico Rapaccini, Alessandro Armuzzi
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. United European gastroenterology journal 7 (9) (2019)
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive diseases and sciences 65 (8) (2019)